Pfizer calls Novo Nordisk's Metsera bid reckless and illegal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Pfizer calls Novo Nordisk's Metsera bid reckless and illegal

Pfizer earnings preview: Leerink trims estimates

November 3, 2025 4:00 PM EST

Pfizer (NYSE: PFE) is set to report third-quarter results on Nov. 4, with analysts at Leerink Partners lowering earnings forecasts ahead of the release.

Leerink reduced its third-quarter earnings-per-share estimate by $0.10, or 13%, to $0.70, and full-year 2025 EPS by 3% to $3.04, within company guidance ($2.90$3.10).

The firm said it cut its 2025 Paxlovid... More